Showing results (231-240 of 375) with videos related to

Sort By:
Pageof 38
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|March 8, 2018
Daytime Sleep Disturbance in Night Shift Work and the Role of PERIOD3Philip Cheng, Gabriel Tallent, Helen J Burgess, et al.
Sleep Advances : a Journal of the Sleep Research Society|May 16, 2023
A two-night polysomnography preliminary study in pregnant women with insomnia: suicidal ideation and nocturnal cognitive arousal prospectively predict objective nocturnal wakefulnessDavid A Kalmbach, Philip Cheng, Thomas Roth, et al.
Sleep Medicine|April 6, 2020
Nocturnal cognitive arousal is associated with objective sleep disturbance and indicators of physiologic hyperarousal in good sleepers and individuals with insomnia disorderDavid A Kalmbach, Daniel J Buysse, Philip Cheng, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|July 16, 2013
Middle-of-the-night hypnotic use in a large national health planThomas Roth, Patricia Berglund, Victoria Shahly, et al.
Bioorganic & Medicinal Chemistry|March 21, 2006
Correlation of the acid-sensitivity of polyethylene glycol daunorubicin conjugates with their in vitro antiproliferative activityPaula C A Rodrigues, Thomas Roth, Heinz H Fiebig, et al.
Sleep|February 16, 2006
Dose-response effects of tiagabine on the sleep of older adultsJames K Walsh, Angela C Randazzo, Sara Frankowski, et al.
Sleep Health|March 9, 2020
Mindfulness and nocturnal rumination are independently associated with symptoms of insomnia and depression during pregnancyDavid A Kalmbach, Thomas Roth, Philip Cheng, et al.
Journal of Clinical Psychopharmacology|September 3, 2014
A generalized estimating equation approach to analysis of maintenance of wakefulness testing in a study of lisdexamfetamine dimesylate, armodafinil, and placebo in sleep-deprived adultsThomas Roth, Jon Freeman, Gary Zammit, et al.
Sleep|November 29, 2007
Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomniaThomas Roth, Roberta Rogowski, Steven Hull, et al.
Sleep|November 25, 2010
Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary InsomniaAndrew D Krystal, H Heith Durrence, Martin Scharf, et al.
Pageof 38